Please log in to view this page
Username
Password
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
